Investor Relations

Prometheus Biosciences is a biotech company pioneering a precision medicine approach for the discovery, development, and commercialization of novel therapeutic and companion diagnostic product candidates. While our initial focus was on IBD, we're now extending beyond gastrointestinal (GI) diseases to target other autoimmune diseases.

Prometheus360TM, our powerful precision medicine platform, combines proprietary technology with the world's most comprehensive collection of IBD patient data, to translate deep, complex data into precision therapeutic and diagnostic product candidates and continually identify new drug targets and unique disease biomarkers. We're headquartered in San Diego, CA.


Investor Relations

Events & Presentations

Jul 28, 2021 at 9:00 AM EDT

Jun 01, 2021 at 11:30 AM EDT

btn Events

Latest Presentation
More information is coming soon.

btn Events


Find SEC filings, quarterly results, and annual reports.

btn Financials


See charters and documents from the Prometheus Biosciences Board of Directors.

btn Governance

IR Contact

Noel Kurdi

btn Resources

Data Provided by Refinitiv. Minimum 15 minutes delayed.

btn Stock